Effect of Cyproterone acetate in patients with Benign Prostatic Hypertrophy
Phase 3
- Conditions
- Benign Prostate Hypertrophy.Enlarged prostate
- Registration Number
- IRCT20181106041572N1
- Lead Sponsor
- Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Male
- Target Recruitment
- 84
Inclusion Criteria
Patients with acute urinary retention complaints with initial diagnosis of BPH.
Exclusion Criteria
Prostate cancer
Urinary infections
Use of sympathomimetic drugs
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method rinary retention. Timepoint: checking of urinary retention immediately after removal of urinary catheter 7 days after starting of cyproterone acetate with ureteral catheter and re-examination one week and 4 weeks after it and follow up to 6 months later. Method of measurement: Observation.
- Secondary Outcome Measures
Name Time Method